281 related articles for article (PubMed ID: 18024097)
1. Therapeutic applications of mesenchymal stromal cells.
Brooke G; Cook M; Blair C; Han R; Heazlewood C; Jones B; Kambouris M; Kollar K; McTaggart S; Pelekanos R; Rice A; Rossetti T; Atkinson K
Semin Cell Dev Biol; 2007 Dec; 18(6):846-58. PubMed ID: 18024097
[TBL] [Abstract][Full Text] [Related]
2. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
Phinney DG; Prockop DJ
Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
[TBL] [Abstract][Full Text] [Related]
3. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W
Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993
[TBL] [Abstract][Full Text] [Related]
4. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
Abdallah BM; Kassem M
J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
6. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell therapy for heart disease.
Gnecchi M; Danieli P; Cervio E
Vascul Pharmacol; 2012 Aug; 57(1):48-55. PubMed ID: 22521741
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells.
Keating A
Curr Opin Hematol; 2006 Nov; 13(6):419-25. PubMed ID: 17053453
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular regeneration using mesenchymal stem cells].
Mathiasen AB; Sørensen MH; Jørgensen E; Ekblond A; Kastrup J
Ugeskr Laeger; 2010 Sep; 172(38):2613-6. PubMed ID: 20920406
[TBL] [Abstract][Full Text] [Related]
10. Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration.
Zhang Y; Liang X; Lian Q; Tse HF
Expert Rev Cardiovasc Ther; 2013 Apr; 11(4):505-17. PubMed ID: 23570363
[TBL] [Abstract][Full Text] [Related]
11. Intra-femoral injection of human mesenchymal stem cells.
Mohanty ST; Bellantuono I
Methods Mol Biol; 2013; 976():131-41. PubMed ID: 23400439
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells: misconceptions and evolving concepts.
Phinney DG; Sensebé L
Cytotherapy; 2013 Feb; 15(2):140-5. PubMed ID: 23321325
[TBL] [Abstract][Full Text] [Related]
13. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P
Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776
[TBL] [Abstract][Full Text] [Related]
14. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.
Horwitz EM; Le Blanc K; Dominici M; Mueller I; Slaper-Cortenbach I; Marini FC; Deans RJ; Krause DS; Keating A;
Cytotherapy; 2005; 7(5):393-5. PubMed ID: 16236628
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair.
Arthur A; Zannettino A; Gronthos S
J Cell Physiol; 2009 Feb; 218(2):237-45. PubMed ID: 18792913
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of emerging applications of mesenchymal stem cells.
Mok PL; Leong CF; Cheong SK
Malays J Pathol; 2013 Jun; 35(1):17-32. PubMed ID: 23817392
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells from iPS cells facilitate periodontal regeneration.
Hynes K; Menicanin D; Han J; Marino V; Mrozik K; Gronthos S; Bartold PM
J Dent Res; 2013 Sep; 92(9):833-9. PubMed ID: 23884555
[TBL] [Abstract][Full Text] [Related]
18. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
Keung EZ; Nelson PJ; Conrad C
Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810
[TBL] [Abstract][Full Text] [Related]
19. Treatment of graft-versus-host-disease with mesenchymal stromal cells.
Kebriaei P; Robinson S
Cytotherapy; 2011 Mar; 13(3):262-8. PubMed ID: 21231805
[TBL] [Abstract][Full Text] [Related]
20. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
